The Association of British Pharmaceutical Industry (ABPI) have published a report showing the UK is leading the rest of Europe for early-stage clinical research into new medicines and vaccines.
The UK’s success in early science has been built on attracting investment and research activity from global pharmaceutical companies to our world-famous universities and research centres. The industry runs thousands of trials around the world at any one time and invests significantly into UK R&D.
At £4.3 billion a year, the industry invests far in excess of any other sector. This report looks at how the UK has built on its legacy of medical innovation to become one of the most competitive global hubs for clinical research and how we compare against Europe and the rest of the world.
To view or download the report click on the image below.
